Validation of the prediction score for inhibitor development in previously untreated patients (PUPs) with severe hemophilia A

被引：0
|
作者：
Hashemi, S. [1 ,2 ,3 ]
Fischer, K. [1 ,2 ]
Van den Berg, H. [3 ]
机构：
[1] UMC Utrecht, Dept Creveldklin & Hematol, Utrecht, Netherlands
[2] UMC Utrecht, Julius Ctr Hlth Sci, Utrecht, Netherlands
[3] UMC Utrecht, Dept Clin Chem & Haematol, Utrecht, Netherlands
来源：
HAEMOPHILIA | 2012年 / 18卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
下载
收藏
页码：89 / 89
页数：1
相关论文
共 50 条
  • [41] RECOMBINANT FVIII (KOGENATE) TREATMENT OF PREVIOUSLY UNTREATED PATIENTS (PUPS) WITH HEMOPHILIA-A - UPDATE OF SAFETY, EFFICACY AND INHIBITOR DEVELOPMENT AFTER 5 STUDY YEARS
    LUSHER, JM
    ARKIN, S
    ABILDGAARD, CF
    HURST, D
    PEDIATRIC RESEARCH, 1995, 37 (04) : A161 - A161
  • [42] Incidence of factor VIII inhibitor in Korean previously untreated hemophilia A patients
    Yoo, Ki Young
    Park, Young Shil
    Kim, Ji Yoon
    HAEMOPHILIA, 2018, 24 : 28 - 28
  • [43] EFFICACY AND SAFETY OF PROPHYLAXIS IN PREVIOUSLY UNTREATED PATIENTS WITH SEVERE HEMOPHILIA A IN IRAN
    Karimi, M.
    Eshghi, P.
    Haghpanah, S.
    Zahedi, Z.
    Habibpanah, B.
    HAEMATOLOGICA, 2015, 100 : 409 - 409
  • [44] Modified Primary Prophylaxis in Previously Untreated Patients With Severe Hemophilia A in Iran
    Karimi, Mehran
    Eshghi, Peyman
    Safarpour, Mohammad M.
    Haghpanah, Sezaneh
    Meshksar, Aidin
    Zahedi, Zohreh
    Habibpanah, Behnaz
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2018, 40 (03) : 188 - 191
  • [45] Modified primary prophylaxis in previously untreated patients with severe hemophilia A in Iran
    Karimi, Mehran
    Eshghi, Peyman
    Meshksar, Aidin
    Safarpour, Mohammad Mostafa
    Haghpanah, Sezaneh
    Zahedi, Zohreh
    Habibpanah, Behnaz
    HAEMOPHILIA, 2016, 22 : 73 - 73
  • [46] ETHICAL DECISION MAKING FRAMEWORK IN PREVIOUSLY UNTREATED SEVERE HEMOPHILIA A PATIENTS
    Lanzel, Ashley Foster
    Soucie, J. Michael
    Ortmann, Leonard
    Barrett, Drue
    Sidonio, Robert, Jr.
    Meeks, Shannon
    PEDIATRIC BLOOD & CANCER, 2018, 65
  • [47] How I approach: Previously untreated patients with severe congenital hemophilia A
    Thornburg, Courtney D.
    PEDIATRIC BLOOD & CANCER, 2018, 65 (12)
  • [48] Ethical Decision Making Framework in Previously Untreated Severe Hemophilia A Patients
    Lanzel, Ashley Foster
    Soucie, J. Michael
    Meeks, Shannon L.
    Sidonio, Robert F.
    Ortmann, Leonard
    Barrett, Drue H.
    BLOOD, 2017, 130
  • [49] RECOMBINANT-FVIII (KOGENATE) TREATMENT OF PREVIOUSLY UNTREATED PATIENTS (PUPS) WITH HEMOPHILIA-A - UPDATE OF SAFETY, EFFICACY, AND INHIBITOR DEVELOPMENT AFTER 5 STUDY YEARS
    LUSHER, J
    ARKIN, S
    ABILDGAARD, CF
    HURST, D
    THROMBOSIS AND HAEMOSTASIS, 1995, 73 (06) : 1012 - 1012
  • [50] INHIBITOR DEVELOPMENT IN PREVIOUSLY UNTREATED PATIENTS (PUPS) WITH HEMOPHILIA RECEIVING KOGENATE - 4.5 YEAR FOLLOW-UP DATA, INCLUDING RESPONSE TO IMMUNE TOLERANCE (IT) WITH KOGENATE
    LUSHER, J
    ARKIN, S
    ABILDGAARD, C
    INWOOD, M
    HILGARTNER, M
    HURST, D
    PEDIATRIC RESEARCH, 1994, 35 (04) : A165 - A165
12345